Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,792 | 33,671 | 314,169 | 329,724 | 132,325 |
| Marketable Securities | 252,449 | 247,452 | 46,538 | 47,312 | 41,393 |
| Receivables | 807 | 2,683 | 1,675 | 876 | 478 |
| TOTAL | $280,904 | $287,489 | $365,687 | $380,926 | $177,451 |
| Non-Current Assets | |||||
| PPE Net | 194 | 189 | 189 | 195 | 185 |
| Investments And Advances | 81,728 | 61,482 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,182 | 5,088 | 3,083 | 1,341 | 1,769 |
| TOTAL | $93,104 | $66,759 | $3,272 | $1,536 | $1,954 |
| Total Assets | $374,008 | $354,248 | $368,959 | $382,462 | $179,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,579 | 7,572 | 3,695 | 2,612 | 2,610 |
| Accrued Expenses | 13,074 | 7,727 | 5,857 | 5,847 | 6,504 |
| TOTAL | $18,452 | $15,710 | $10,029 | $8,959 | $9,631 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 479 | 100 | 100 | 100 | 100 |
| Other Non-Current Liabilities | 1,171 | 0 | 30 | 97 | 168 |
| TOTAL | $3,079 | $640 | $712 | $816 | $904 |
| Total Liabilities | $21,531 | $16,350 | $10,741 | $9,775 | $10,535 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,125 | 29,597 | 29,354 | 29,349 | 29,347 |
| Common Shares | 31 | 29 | 29 | 29 | 15 |
| Retained earnings | -174,392 | -145,952 | -120,778 | -103,171 | -89,423 |
| Other shareholders' equity | 106 | 681 | -37 | -27 | 47 |
| TOTAL | $352,477 | $337,898 | $358,218 | $372,687 | $168,870 |
| Total Liabilities And Equity | $374,008 | $354,248 | $368,959 | $382,462 | $179,405 |